Therapy Areas: Oncology
16 November 2026 - CARsgen Therapeutics Holdings Limited (HK:2171), a Chinese developer of innovative CAR T-cell therapies, announced on Saturday that satricabtagene autoleucel (satri-cel, product cod...
16 November 2026 - Precision medicine oncology company IDEAYA Biosciences Inc (Nasdaq:IDYA) on Sunday announced the development candidate nomination of IDE101, a potential first-in-class dual cyclin-d...
16 November 2026 - Biopharmaceutical company Specialised Therapeutics announced on Sunday that the Thailand Food and Drug Administration has approved YONDELIS (trabectedin) for the treatment of adult ...
13 November 2026 - Rezolute, Inc. (NASDAQ: RZLT), a late-stage metabolic disease company focused on treating refractory hypoglycemia caused by hyperinsulinism, said preliminary results from a data eva...
13 November 2026 - PAI Pharma (PAI), a portfolio company of Olympus Partners and a US-based developer, manufacturer, and marketer of oral liquid medicines and Ready-To-Use (RTU) sterile injectables, a...
13 November 2026 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company that develops, manufactures, and commercialises medicines for the treatment of oncology, autoimmune, ...